Gateway Investment Advisers LLC Charles River Laboratories International, Inc. Transaction History

Gateway Investment Advisers LLC

$9 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$206.39 - $268.73 $96,384 - $125,496	-467 Reduced 32.32%	978 $202,000
Q1 2024 Apr 12, 2024	SELL	$203.52 - $273.43 $7,123 - $9,570	-35 Reduced 2.36%	1,445 $391,000
Q4 2023 Jan 09, 2024	BUY	$164.52 - $238.84 $36,852 - $53,500	224 Added 17.83%	1,480 $349,000
Q3 2023 Oct 19, 2023	SELL	$194.44 - $217.61 $34,610 - $38,734	-178 Reduced 12.41%	1,256 $246,000
Q2 2023 Jul 13, 2023	SELL	$183.71 - $210.25 $5,695 - $6,517	-31 Reduced 2.12%	1,434 $301,000
Q1 2023 Apr 11, 2023	SELL	$191.89 - $259.92 $5,181 - $7,017	-27 Reduced 1.81%	1,465 $295,000
Q4 2022 Jan 13, 2023	BUY	$197.11 - $250.07 $45,138 - $57,266	229 Added 18.13%	1,492 $0
Q3 2022 Oct 07, 2022	SELL	$182.44 - $250.54 $120,045 - $164,855	-658 Reduced 34.25%	1,263 $249,000
Q2 2022 Jul 13, 2022	BUY	$204.13 - $302.4 $65,729 - $97,372	322 Added 20.14%	1,921 $411,000
Q1 2022 Apr 14, 2022	SELL	$255.51 - $362.11 $24,273 - $34,400	-95 Reduced 5.61%	1,599 $454,000
Q4 2021 Jan 14, 2022	BUY	$351.38 - $448.68 $50,598 - $64,609	144 Added 9.29%	1,694 $638,000
Q2 2021 Jul 13, 2021	SELL	$294.17 - $371.65 $86,780 - $109,636	-295 Reduced 15.99%	1,550 $573,000
Q1 2021 Apr 14, 2021	SELL	$249.67 - $299.48 $74,401 - $89,245	-298 Reduced 13.91%	1,845 $535,000
Q4 2020 Jan 14, 2021	BUY	$222.0 - $252.62 $3,330 - $3,789	15 Added 0.7%	2,143 $535,000
Q3 2020 Oct 19, 2020	SELL	$175.56 - $226.45 $14,922 - $19,248	-85 Reduced 3.84%	2,128 $482,000
Q2 2020 Jul 15, 2020	SELL	$118.84 - $189.72 $22,817 - $36,426	-192 Reduced 7.98%	2,213 $386,000
Q1 2020 Apr 13, 2020	BUY	$98.9 - $178.34 $19,186 - $34,597	194 Added 8.77%	2,405 $304,000
Q4 2019 Jan 09, 2020	SELL	$126.05 - $152.76 $32,646 - $39,564	-259 Reduced 10.49%	2,211 $338,000
Q2 2019 Jul 17, 2019	SELL	$123.4 - $148.55 $10,489 - $12,626	-85 Reduced 3.33%	2,470 $350,000
Q1 2019 Apr 10, 2019	SELL	$104.82 - $146.73 $12,368 - $17,314	-118 Reduced 4.41%	2,555 $371,000
Q4 2018 Jan 14, 2019	BUY	$105.09 - $137.23 $7,146 - $9,331	68 Added 2.61%	2,673 $303,000
Q2 2018 Jul 11, 2018	BUY	$102.37 - $117.25 $266,673 - $305,436	2,605 New	2,605 $292,000

Others Institutions Holding CRL

# of Institutions

695

Shares Held

52.2M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.13 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$945 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$695 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$396 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$360 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Account